[HTML][HTML] Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis
BACKGROUND Elevated levels of inflammatory cytokines have been associated with poor
outcomes among COVID-19 patients. It is unknown, however, how these levels compare …
outcomes among COVID-19 patients. It is unknown, however, how these levels compare …
Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors
H Han, Q Ma, C Li, R Liu, L Zhao, W Wang… - Emerging microbes & …, 2020 - Taylor & Francis
Since the outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China, it has rapidly
spread across many other countries. While the majority of patients were considered mild …
spread across many other countries. While the majority of patients were considered mild …
[HTML][HTML] Clinical and pathological investigation of patients with severe COVID-19
BACKGROUND. Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
coronavirus 2 (SARS-CoV-2), has become a pandemic. This study addresses the clinical …
coronavirus 2 (SARS-CoV-2), has become a pandemic. This study addresses the clinical …
Cytokines and their relationship with the severity and prognosis of coronavirus disease 2019 (COVID-19): a retrospective cohort study
QQ Liu, A Cheng, Y Wang, H Li, L Hu, X Zhao… - BMJ open, 2020 - bmjopen.bmj.com
Objective To delineate the characteristics and clinical significance of plasma inflammatory
cytokines altered in COVID-19. Design Retrospective, single-centre cohort study. Setting …
cytokines altered in COVID-19. Design Retrospective, single-centre cohort study. Setting …
Distinct cytokine profiles associated with COVID-19 severity and mortality
K Dorgham, P Quentric, M Gökkaya, S Marot… - Journal of Allergy and …, 2021 - Elsevier
Background Markedly elevated levels of proinflammatory cytokines and defective type-I
interferon responses were reported in patients with coronavirus disease 2019 (COVID-19) …
interferon responses were reported in patients with coronavirus disease 2019 (COVID-19) …
[HTML][HTML] Dynamic changes in serum IL-6, IL-8, and IL-10 are associated with the outcome of patients with severe COVID-19 in ICU
J Li, L Rong, R Cui, J Feng, Y Jin, Y Yu, X Chen, R Xu - 2020 - europepmc.org
Background: Biomarkers that would help prognosticate outcomes and guide treatment of
patients with severe coronavirus disease 2019 (COVID-19) are currently required. We aimed …
patients with severe coronavirus disease 2019 (COVID-19) are currently required. We aimed …
[HTML][HTML] Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease
Y Zhao, L Qin, P Zhang, K Li, L Liang, J Sun, B Xu… - JCI insight, 2020 - ncbi.nlm.nih.gov
BACKGROUND. Identifying immune correlates of COVID-19 disease severity is an urgent
need for clinical management, vaccine evaluation, and drug development. Here, we present …
need for clinical management, vaccine evaluation, and drug development. Here, we present …
Immunity and inflammatory biomarkers in COVID‐19: a systematic review
APD Iwamura, MR Tavares da Silva… - Reviews in Medical …, 2021 - Wiley Online Library
Summary Coronavirus disease 2019 (COVID‐19) is a clinical syndrome caused by the
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) virus. Patients can be …
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) virus. Patients can be …
[HTML][HTML] Pro-and anti-inflammatory responses in severe COVID-19-induced acute respiratory distress syndrome—an observational pilot study
Q Notz, M Schmalzing, F Wedekink… - Frontiers in …, 2020 - frontiersin.org
Objectives The severity of Coronavirus Disease 2019 (COVID-19) is largely determined by
the immune response. First studies indicate altered lymphocyte counts and function …
the immune response. First studies indicate altered lymphocyte counts and function …
[HTML][HTML] Clinical utility of inflammatory biomarkers in COVID-19 in direct comparison to other respiratory infections—A prospective cohort study
M Lampart, N Zellweger, S Bassetti, S Tschudin-Sutter… - PloS one, 2022 - journals.plos.org
Background Inflammatory biomarkers are associated with severity of coronavirus disease
2019 (COVID-19). However, direct comparisons of their utility in COVID-19 versus other …
2019 (COVID-19). However, direct comparisons of their utility in COVID-19 versus other …
相关搜索
- covid 19 ards and sepsis
- cytokine profile ards and sepsis
- covid 19 dynamic changes
- covid 19 outcome of patients
- covid 19 serum il 6
- covid 19 inflammatory biomarkers
- covid 19 lymphocyte subsets
- covid 19 direct comparison
- covid 19 severity and prognosis
- covid 19 clinical utility
- covid 19 coronavirus disease
- cytokine levels lymphocyte subsets
- cytokine levels dynamic changes
- covid 19 cytokine profile
- covid 19 cytokine levels
- covid 19 serum cytokines